EP1226272A2 - Sondes pour acide nucleique a brin double et leur utilisation - Google Patents
Sondes pour acide nucleique a brin double et leur utilisationInfo
- Publication number
- EP1226272A2 EP1226272A2 EP00969512A EP00969512A EP1226272A2 EP 1226272 A2 EP1226272 A2 EP 1226272A2 EP 00969512 A EP00969512 A EP 00969512A EP 00969512 A EP00969512 A EP 00969512A EP 1226272 A2 EP1226272 A2 EP 1226272A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleic acid
- double
- stranded nucleic
- stranded
- acid probes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108020004711 Nucleic Acid Probes Proteins 0.000 title claims abstract description 59
- 239000002853 nucleic acid probe Substances 0.000 title claims abstract description 59
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 146
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 132
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 132
- 230000003993 interaction Effects 0.000 claims abstract description 40
- 238000001514 detection method Methods 0.000 claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000000523 sample Substances 0.000 claims description 58
- 239000000126 substance Substances 0.000 claims description 57
- 238000000034 method Methods 0.000 claims description 50
- 108020004414 DNA Proteins 0.000 claims description 46
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 102000040945 Transcription factor Human genes 0.000 claims description 30
- 108091023040 Transcription factor Proteins 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 230000008859 change Effects 0.000 claims description 22
- 238000009396 hybridization Methods 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 230000015572 biosynthetic process Effects 0.000 claims description 17
- 102000053602 DNA Human genes 0.000 claims description 16
- -1 repressors Proteins 0.000 claims description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 239000012429 reaction media Substances 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 230000000295 complement effect Effects 0.000 claims description 8
- 238000009830 intercalation Methods 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 5
- 239000000824 cytostatic agent Substances 0.000 claims description 4
- 230000001085 cytostatic effect Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 230000000711 cancerogenic effect Effects 0.000 claims description 3
- 231100000315 carcinogenic Toxicity 0.000 claims description 3
- 230000002860 competitive effect Effects 0.000 claims description 3
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 claims description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 1
- 239000012327 Ruthenium complex Substances 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 65
- 108091034117 Oligonucleotide Proteins 0.000 description 53
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 44
- 238000011534 incubation Methods 0.000 description 42
- 239000010931 gold Substances 0.000 description 30
- 238000009739 binding Methods 0.000 description 28
- 230000027455 binding Effects 0.000 description 27
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 26
- 229910052737 gold Inorganic materials 0.000 description 26
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 239000000370 acceptor Substances 0.000 description 20
- 239000000284 extract Substances 0.000 description 19
- 238000005259 measurement Methods 0.000 description 16
- 239000012148 binding buffer Substances 0.000 description 14
- 230000007423 decrease Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 102000006290 Transcription Factor TFIID Human genes 0.000 description 11
- 108010083268 Transcription Factor TFIID Proteins 0.000 description 11
- 239000012634 fragment Substances 0.000 description 11
- 238000001903 differential pulse voltammetry Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 9
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 9
- 239000008363 phosphate buffer Substances 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000002356 single layer Substances 0.000 description 8
- 108010003118 Bacteriochlorophylls Proteins 0.000 description 7
- 239000003298 DNA probe Substances 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 7
- 238000002484 cyclic voltammetry Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DSJXIQQMORJERS-AGGZHOMASA-M bacteriochlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC([C@H](CC)[C@H]3C)=[N+]4C3=CC3=C(C(C)=O)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 DSJXIQQMORJERS-AGGZHOMASA-M 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000027756 respiratory electron transport chain Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 102000006467 TATA-Box Binding Protein Human genes 0.000 description 5
- 108010044281 TATA-Box Binding Protein Proteins 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- 102100030246 Transcription factor Sp1 Human genes 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- 108010054278 Lac Repressors Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 102000009097 Phosphorylases Human genes 0.000 description 3
- 108010073135 Phosphorylases Proteins 0.000 description 3
- 239000012317 TBTU Substances 0.000 description 3
- 101710183280 Topoisomerase Proteins 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 239000008366 buffered solution Substances 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000000138 intercalating agent Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000013580 millipore water Substances 0.000 description 3
- 239000003607 modifier Substances 0.000 description 3
- 150000008300 phosphoramidites Chemical class 0.000 description 3
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- UGZAJZLUKVKCBM-UHFFFAOYSA-N 6-sulfanylhexan-1-ol Chemical compound OCCCCCCS UGZAJZLUKVKCBM-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010092160 Dactinomycin Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 101710196632 LexA repressor Proteins 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108010053551 Sp1 Transcription Factor Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 101710085924 Transcription factor Sp1 Proteins 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 108050004197 Trp repressor Proteins 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
- 238000010640 amide synthesis reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 102000023732 binding proteins Human genes 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229960000640 dactinomycin Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 230000005283 ground state Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- AFQIYTIJXGTIEY-UHFFFAOYSA-N hydrogen carbonate;triethylazanium Chemical compound OC(O)=O.CCN(CC)CC AFQIYTIJXGTIEY-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000005783 single-strand break Effects 0.000 description 2
- 238000001542 size-exclusion chromatography Methods 0.000 description 2
- 238000010583 slow cooling Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- CWYYTRHMNNPRNR-KVQBGUIXSA-N (2r,3s,5r)-5-(6-amino-8-azidopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol Chemical compound [N-]=[N+]=NC1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 CWYYTRHMNNPRNR-KVQBGUIXSA-N 0.000 description 1
- AKIZPWSPNKVOMT-UHFFFAOYSA-N 1-sulfanylhexan-1-ol Chemical compound CCCCCC(O)S AKIZPWSPNKVOMT-UHFFFAOYSA-N 0.000 description 1
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- JYJKEJRADFTGCE-KVQBGUIXSA-N 2-azido-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purin-6-one Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC(N=[N+]=[N-])=NC(O)=C2N=C1 JYJKEJRADFTGCE-KVQBGUIXSA-N 0.000 description 1
- VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 1
- BYMHPNQECCIGDF-UHFFFAOYSA-N 2-hydroxysulfanylethanol Chemical compound OCCSO BYMHPNQECCIGDF-UHFFFAOYSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- VIWPPFXRYOIYFA-UHFFFAOYSA-N 3-(ethyliminomethylideneamino)propane-1,1-diamine Chemical compound CCN=C=NCCC(N)N VIWPPFXRYOIYFA-UHFFFAOYSA-N 0.000 description 1
- ISCMYZGMRHODRP-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCN=C=N ISCMYZGMRHODRP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000702560 Homo sapiens Probable global transcription activator SNF2L1 Proteins 0.000 description 1
- 101000702544 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 102000044753 ISWI Human genes 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 101100144701 Mus musculus Drosha gene Proteins 0.000 description 1
- 150000004008 N-nitroso compounds Chemical class 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001356 alkyl thiols Chemical class 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- 230000008841 allosteric interaction Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- XZSVAMUZTKNGDN-JBRJOJLESA-L bacteriochlorophylls Chemical class [Mg+2].[N-]1C2=C(C=3C(C(C)C(=CC=4C(=C(C(C)=O)C(=C5)N=4)C)N=3)CCC(=O)OC\C=C(/C)CCCC(C)CCCC(C)CCCC(C)C)C(C(=O)OC)C([O-])=C2C(C)=C1C=C1C(CC)C(C)C5=N1 XZSVAMUZTKNGDN-JBRJOJLESA-L 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 229960005243 carmustine Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000000451 chemical ionisation Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 238000005661 deetherification reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001687 destabilization Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 238000003541 multi-stage reaction Methods 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical class C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001718 repressive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 150000003303 ruthenium Chemical class 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004365 square wave voltammetry Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
Definitions
- the present invention relates to electronically readable double-stranded nucleic acid derivatives and their use for the quick and easy detection of interactions between double-stranded nucleic acids and factors which interact directly or indirectly with them, in particular with proteins, peptides, single-stranded or double-stranded nucleic acids or substances which damage nucleic acids.
- Double-stranded nucleic acids play a crucial role in the living cell and also in many viruses, especially as carriers of the hereditary system. They are subject to natural systems such as B. a cell of various internal and external influences. Interactions between proteins and double-stranded DNA are of particular interest, since such interactions have a decisive influence on the transcription or repression of individual genes and thus on the phenotype of the corresponding organisms. But also the replication of the hereditary system in mitosis or meiosis, the restriction z. B. viral nucleic acids or the packing and unpacking of eukaryotic nucleic acids in the chromosomes are other important processes in living cells that are controlled by the complex interplay of proteins and nucleic acids.
- nucleic acids themselves, whether single-stranded or double-stranded, can with their double-stranded relatives, e.g. B. in the recombination, insertion or transposition, interact.
- the methods described are limited to the detection of hybridized single-stranded nucleic acids.
- the detection is limited to the mere presence of a target sequence in the medium to be examined and, moreover, does not allow any statements about the biological activity of the interacting nucleic acids.
- a radioactively labeled DNA sequence is an incomplete restriction degradation, eg. B. subjected to DNAse I. The sequence is protected from degradation at the corresponding site by a bound protein; the corresponding bands are missing in the electrophoretic fragment detection compared to the free sequence.
- the object of the present invention is to provide novel probes for the detection and analysis of interactions of double-stranded nucleic acids as well as methods for the rapid and simple detection of such interactions.
- the task is accomplished with the help of new, electronically readable double-strand
- the probes contain at least partially double-stranded nucleic acids or single-stranded nucleic acids with self-recognizing domains which are attached to a conductive surface, preferably to an electrode, e.g. B. are bound to field effect transistors.
- the nucleic acid section present as a duplex is linked to at least one electron donor unit or alternatively to at least one electron acceptor unit, with at least a portion of the nucleic acid region to be investigated between the electrode and the electron acceptor unit or electron donor unit lies. This sub-area forms the detection point.
- the binding of the individual probe subunits can take place covalently or via stable supramolecular interactions, such as van der Waals interactions, dipole interactions, especially hydrogen bonds, or ionic interactions.
- All single-stranded or double-stranded nucleic acids of any sequence can be used to construct the probe. It is irrelevant whether natural, synthetic or modified nucleic acid sequences are used.
- the corresponding double strand can be formed simply by hybridization with a complementary single-stranded nucleic acid (e.g. McCarthy, BJ et al., "Specificity of Moiecular Hybridization Reaction” Annu. Rev. Biochem. (1970), 39 , 131-150), the formation of a double strand in the case of self-complementary single-stranded nucleic acids being caused by intramolecular refolding.
- a complementary single-stranded nucleic acid e.g. McCarthy, BJ et al., “Specificity of Moiecular Hybridization Reaction” Annu. Rev. Biochem. (1970), 39 , 131-150
- two domains with more complementary sequences are advantageously covalently linked via a bridge comprising at least one nucleotide, preferably one from 4 to A bridge consisting of 6 nucleotides, in particular of thymine nucleotides, or linked via an artificial, at least one atomic bridge, such as disulfide bridges (Hetian Gao et al., “Stabilization of double-stranded oligonucleotides using backbone-linked disulfide bridges ", Nucleic Acid Research, 1995, Vol. 23, No.
- Modifier-CPG (GlenResearch), which is preferably built on a thiol support, or branched phosphoramidite bridges.
- a great advantage of such nucleic acids containing self-complementary sequence segments lies in the simple, fully synthetic accessibility of the single-stranded nucleic acid and the simple manufacture of the double-stranded probe from a single molecular nucleic acid subunit.
- Hybridization of the single-stranded self-complementary sequence segments containing nucleic acids is independent of the nucleic acid concentration. Another advantage of this process is that it can be produced enzyme-free. Another advantage is therefore that the double-stranded nucleic acid probes can also be prepared under denaturing conditions. A hairpin-forming single-stranded sequence with a free 3 ' OH end can also be obtained using a DNA or RNA polymerase, e.g. B. a Klenow or Taq polymerase to the corresponding nucleic acid duplex are completed.
- a DNA or RNA polymerase e.g. B. a Klenow or Taq polymerase to the corresponding nucleic acid duplex are completed.
- RNAs can be used.
- modified derivatives include, in particular, nucleic acids which contain nucleotides modified on the sugar, such as 2 , O-methyl nucleotides or 2 ' O-allyl nucleotides.
- a modification of the phosphate group such as. B. to phosphoramide, phosphorothioate or
- Methylphosphonate is also possible. It is also possible to use nucleic acids which contain no sugar or a sugar which does not occur in natural nucleic acids, such as. B. the peptidyl nucleic acids or the pyranosyl nucleic acids. In addition to those modified on the sugar-phosphate backbone ⁇ > Nucleic acids can also be used as probe components that contain non-naturally occurring nucleotides such as xanthine, hypoxanthine or inosine.
- Double-stranded DNA or RNA nucleic acid sequences are preferably incorporated into the probes.
- Naturally occurring proteins or peptides binding DNA sequences in particular DNA sequences involved in gene regulation, such as. B. operator or promoter sequences.
- DNA sequences involved in gene regulation such as. B. operator or promoter sequences.
- consensus sequences or allele-specific or organism-specific sequences can be expedient.
- the length of the nucleic acid sequence between the electrode and the electron donor units or electron acceptor units is preferably between 2 and 100 base pairs, particularly preferably between 5 and 50 base pairs.
- the double-stranded area must extend to the nucleic acid electrode linker in order to ensure an electron flow.
- Single-stranded areas can extend beyond the double-stranded detection region lying between the electrode and the electron donor units or electron acceptor units.
- the double-stranded detection region can contain single-strand breaks in the sugar-phosphate backbone.
- a double strand can by chemical modifications that lead to inter- or intramolecular bridge bonds, such as. B. disulfide bridges, or other non-natural strand subunits can be chemically stabilized.
- Another possibility of stabilizing the nucleic acid duplex sections is the targeted introduction of thymine nucleotides at two opposite positions in the duplex and subsequent radiation-induced thymidine bridge formation.
- azido nucleotides or psoralen derivatives can also be used for photoinduced bridging (Fabrega, C.
- All molecules, parts of molecules or surfaces which are able to donate electrons from their ground state or from an excited state or to take up electrons in the ground state or in an activated state can act as electron donor units or electron acceptor units.
- the excitation of an electron donor unit can e.g. B. done by exposure to light or ionization, the activation of an electron acceptor z. B. by ionization also by means of light or by chemical ionization.
- Proven electron donors and acceptors are e.g. B. metal complexes or organic redox-active compounds, as described in patent application WO 96/40712 or naturally occurring or modified photo-inducible redox-active reaction centers such as z. B. can be used in the patent application DE 19901761 A1.
- electrically conductive surfaces, in particular electrodes can also be used as donor or acceptor units.
- the use of ferrocene or PQQ as electron donor units has proven itself experimentally.
- the covalently bound electron donor units or electron acceptor units can be integrated in multimolecular electron transfer systems.
- the electron donor unit (electron acceptor units) acting in the double-stranded nucleic acid probe can be dissolved electron donors such as e.g. Anions (cations) can be charged in a regenerable manner, with a closed circuit being built up using the double-stranded nucleic acid probes as a resistor.
- anions cations
- other redox-active electron transfer units may be associated with the covalently bound electron donor or acceptor unit.
- Inducible and / or regenerative donor or acceptor units are preferred. Regenerative systems enable a continuous flow of electrons through the duplex nucleic acid, while in inducible systems the flow of electrons through the inductor can be controlled over time.
- the electron flow can be induced analogously to the natural photosynthesis processes by exposure to light.
- suitable electron donating dissolved substances such as. B. Fe (CN) 3 " or Fe (CN) ⁇ 4"
- the reaction centers can be regenerated again.
- Induction can also take place directly via chemical substances which transfer electrons to the electron donor units or withdraw electrons from the electron acceptor units.
- connection of the nucleic acids to the electrode can e.g. via a thiol group (Chidsey, C.E.D., Sience, V. 251, p. 919, (1991)) or via phosphorothioates or phosphorodithioates on a gold surface.
- a connection via highly conductive molecule linkers e.g. described by Kayyem et al. In WO 98/20162
- linkers with conjugated double bond systems allows electron conduction along the linker structure to the electrode surface. This elegantly enables passivation of the free electrode surface.
- the double-stranded nucleic acid probes can be connected to an unstructured, coherent electrode surface or to a structured, e.g. B. matrix-shaped electrode array surface.
- the structuring takes place in such a way that the individual array positions of the electrode can be read independently of one another.
- the individual array positions can be assigned nucleic acid probes with specific sequences, or the reaction space can be compartmentalized. A high degree of parallelization can thus be achieved in the electronic reading of the electrode.
- the double-stranded nucleic acid probes according to the invention offer the possibility of detecting factors interacting with nucleic acid double-strands by changing the conductivity.
- Interacting factors are chemical substances or radiation that interact with a nucleic acid duplex and trigger a change in the primary, secondary, tertiary or quaternary structure of the duplex. These structural changes lead to a significant change in the electrical resistance of the duplex structure and thus to a change in the electron flow along the double-stranded nucleic acid.
- other effects such as B.
- Changes in the electrical conductivity of double-stranded nucleic acids are e.g. B. by the binding of proteins or peptides such as antibodies, polymerases, transcription factors, enhancers or repressors, the activity of which in turn by indirectly acting substances such as. B. can be modulated via inductors or modifying enzymes.
- Organic molecules such as some hormones can also be used directly or in conjunction with proteins or peptides such as e.g. B. hormone receptors, interact with double-stranded nucleic acids.
- Single-stranded nucleic acid can also, for. B. interact with triplex formation with double-stranded nucleic acids. But also saline solutions, mimetics or substances intercalating into the nucleic acid duplex, including cytostatics like the anthracyclines, cause measurable changes in the structure of the double strand.
- Topoisomerases cause single strand breaks and linkages. But also mimetics, nucleic acid-damaging substances and cytostatics that z. B. alkylating on nucleic acids or cross-linking, such as platinum complexes, for. B. cisplatin, methanesulfonates, e.g. B. busulfan, or n-nitroso compounds, for example Carmustine can attack their covalent bonds and / or new covalent ones
- Radioactive and electromagnetic radiation such as. B. ⁇ -, ß-, ⁇ - or UV radiation can also lead to such structural changes and thus to a measurable change in the electron flow within the double-stranded nucleic acid.
- the use of the double-stranded nucleic acid derivatives according to the invention as probes offers many advantages. All interactions to which a double-stranded nucleic acid probe is exposed and which have an effect on the electrical conductivity can be detected.
- the measurement can be coulombmetric, impedometric, preferably frequency-dependent resistive or capacitive, voltammetric, potentiometric or amperometric.
- the disruptive effect of ions directly discharged at the electrode from the reaction solution is surprisingly very low.
- the electron flow can be frequency-modulated by the double-stranded nucleic acid probe. When using photo-inducible electron donor units, the modulation can take place via flashes of light.
- Very small changes in conductivity can also be detected via the number of probes applied or by extending the measuring time.
- the number of probes is preferably selected so that the current change resulting from the interaction between the double-stranded nucleic acid and the factors interacting with it is at least in the nA range. Due to the particularly high sensitivity, cyclovoltammetry, differential pulse voltammetry and square wave voltammetry have proven to be a particularly suitable measurement method.
- Another advantage of the present probes is their high compatibility with a wide variety of reaction media.
- the use of crude extracts as the reaction medium or the use of reaction media with a salt concentration corresponding to the natural conditions are of interest.
- the kinetics of double-stranded nucleic acid interactions can be examined and equilibrium constants of double-stranded nucleic acids with interacting substances can be determined. That offers the Possibility to find antagonists and allosteric interactions with other factors and to determine their activity. Investigations can be carried out as a multi-step reaction in which individual factors are pipetted to the reaction solution in succession during the measuring process.
- the probes according to the invention are particularly suitable for the investigation of gene regulation, in particular the transcription or repression of genes.
- a large number of substances that directly interact with the double-stranded DNA play a role in gene regulation, such as RNA polymerases, transcription factors, repressors or enhancers or which only have an indirect effect, such as, for example, B. inducers, enzymes, such as phosphorylases, second messengers, such as cAMP or cGMP, receptors and their binding partners, such as hormones, play an important role.
- the signal chains that lead to the transcription or repression of individual genes can be extremely complex.
- the probes according to the invention can provide important insights in elucidating the interaction of the individual factors.
- z. B known regulatory DNA sequences of a gene incorporated into the probes.
- the probes are applied to an electrode surface so that the sum of the change in the electrical conductivity of the double-stranded DNA probes is measured.
- the reference electron flow through the probes is determined in the presence of a reference solution.
- the reference value can also be determined using a standard electrochemical cell / electrode.
- the reference solution ideally contains all components of the reaction solution except the factors to be tested.
- the reference electron flow is modulated by the gradual addition of the individual substances to be tested.
- the change in the electron flow then provides information about a successful interaction between the test substance and the probe sequence, the strength of the change in the electron flow provides information the strength of the interaction and the equilibrium constant of the binding reaction.
- the effect of other factors influencing the activity of these substances can be determined indirectly by changing the equilibrium constants of RNA polymerases, transcription factors or repressors.
- reaction solutions containing different factors can be tested or the indirectly acting factors are successively introduced into the reaction solution.
- Interactions between individual substances within the regulatory signal chains can be determined.
- the lactose operon from Escherichia coli offers an example of such an induction mechanism.
- the effect of the lac repressor is canceled by the presence of lactose, the repressor loses its affinity for the operator sequence and the electron flow will adjust to the reference value. If ⁇ -galactosidase, a lactose-degrading enzyme, is added to the reaction solution, the lac repressor is reactivated.
- lexA repressor in E. coli, which regulates numerous genes that are involved in DNA repair. RecA proteins bound by single-strand DNA are proteolytically cleaved and thus from 23 associated operator replaced. The electron flow within the double-stranded DNA probe will consequently adjust to the reference value again.
- the degree of alignment of the electron flow with the reference electron flow is a measure of the strength of the inductive effect.
- concentration-dependent effects of the inductor on the repressor or a linear dependence of the induction on the inductor concentration can be determined.
- the electron flow remains at the reference value.
- a regulatory mechanism is e.g. B. in the tryptophan operon of E. coli.
- the trp repressor is activated by the presence of tryptophan and the repressor tryptophan complex binds to the associated operator sequence. A deviation of the electron flow within the double-stranded DNA probes from the reference value can be determined.
- probes can be used which contain a promoter sequence.
- a reference value can then be determined, which is modulated by adding individual factors.
- a change in the reference value indicates an interaction of the added substance.
- the RNA polymerases and transcription factors that bind in the promoter area can then be identified.
- the binding of the transcription factor Sp1 which specifically binds to this promoter can be determined.
- second messenger or modifying enzymes such as. B. phosphorylases, or transcription Influencing molecules, like some antibiotics, their activating or inhibiting influence on the transcription factor-DNA binding is measurable.
- transcription factor p53 the gene product of a tumor suppressor gene.
- p53 can by adding a phosphorylase, in the presence of a suitable phosphate donor, such as. B. ATP, phosphorylated and thus activated.
- a suitable phosphate donor such as. B. ATP
- the electron flow changes continuously due to the binding of the phosphorylated p53 to the probe sequence up to a concentration-dependent saturation value.
- information about the reaction rate can then be obtained from the slope of the electron flow-time curve. The greater the slope of the curve, the higher the reaction rate, in the example of the phosphorylation reaction.
- the DNA sequence of the probes includes the operator and the promoter
- competitive effects between RNA polymerases, promoter-binding transcription factors and repressors can also be measured.
- Ousted z. B. a repressor an already bound transcription factor the electron flow changes accordingly. The measured electron flows lie between the values for the reaction solutions containing only one RNA polymerase and / or the transcription factor and only the repressor. So z. B. the direct influence of the lac, trp or lexA repressor on the RNA polymerase binding to the promoter can be investigated.
- a particular advantage of the method described here is the possibility of investigating allele-specific interactions between regulatory active substances and the associated DNA regulation sequences.
- the different activity of DNA sequences and DNA-binding proteins or peptides of the wild type and mutated DNA sequences, proteins or peptides can be carried out in separate batches independently of phenotypically recognizable changes to be examined.
- the study of recessive characteristics is possible.
- Heterozygous organisms with regard to the transcription factor result in an electron flow through the double-stranded nucleic acid probe which lies between the two extracts from the homozygous organisms, in this case extracts with a certain concentration have to be used.
- the method is not limited to the identification of substances that participate in gene regulation.
- B. also bind histones, helicases, topoisomerases or ligases to double-stranded DNA. While helicases, topoisomerases and chromatin remodulating enzymes (e.g. nucleosomal ATPase ISWI) can generally reduce the flow of electrons through the probes if double-stranded nucleic acid probes are used which contain one or more bond breaks in the sugar-phosphate backbone that are ligated also lead to an electron flux increase.
- nucleosomal ATPase ISWI nucleosomal ATPase ISWI
- RNAsen recognize and break down the RNA parts within a double strand.
- the loss of the RNA building blocks generates a single strand that can now be detected due to the loss of conductivity. Not all of the RNA has to be broken down, even the loss of one or two Ribonucleotides between the electron donor units or electron acceptor units and the electrode result in a drastic decrease in the conductivity in the double strand.
- DNAse can be detected with double-stranded DNA probes.
- restriction enzymes such as. B. Hind IM which catalyzes a smooth double-strand break or EcoR I or PST I which produces an offset double-strand break, provided a suitable restriction site is present in the double-strand sequence.
- Nucleic acid strands between the electron donor units or electron acceptor units and the electrode completely stop the flow of electrons through the double strand.
- the binding sequences of individual nucleic acid-binding substances can also be determined with the aid of the double-stranded nucleic acid probes according to the invention.
- Electrode arrays are advantageously used for this purpose, in which each field is connected to a group of double-stranded nucleic acids of a precisely defined sequence. In the ideal case, all possible 4 ⁇ sequences, where n is the number of base pairs, can be read out electronically on the electrode in 4 n
- Double-stranded nucleic acid binding factors modulate the conductivity of the array positions that contain a sequence that is recognized by the factor.
- the associated recognized sequence is determined via the corresponding array position.
- Hybridization methods the associated genes can be identified. With this method, modified nucleic acid sequences or transcription factors produced by site-specific mutagenesis can also be evaluated. A strong nucleic acid transcription factor / RNA polymerase binding is an indication of a highly active transcription-promoting complex. The selection of highly active promoter sequences and the associated highly active transcription factors is thus possible. Such promoter / transcription factor complexes can be used to construct novel expression vectors. Extracts of regulatory fragments of DNA fragments of not exactly specified sequences of a specific gene can also be incorporated into the double-stranded nucleic acid probes. Known factors of certain concentration binding to these sequences can then be used to determine whether homozygous binding sequences, homozygous non-binding sequences or heterozygous sequence mixtures are present in the probes.
- nucleic acid fragment extract can be added directly to a double-stranded nucleic acid probe / probe-binding protein. The competitive effect of the nucleic acid fragment extract on the measuring system is then measured.
- single- or double-stranded nucleic acids can also interact with the probe sequences.
- the at least partial separation of the nucleic acid double strand of the probe due to the hybridization of the single-stranded nucleic acids competing as binding partners with a complementary probe sequence leads to triplex structures or to a dissolution of the probe duplex by re-hybridization. This will interrupt or change the conductivity of the probe. Hybridization events can thus be detected with this method. If a destabilized double-stranded nucleic acid sequence is used in the probe, hybridization with a single-stranded nucleic acid in solution is facilitated. A destabilization against a DNA double strand can e.g. B. can be achieved through the use of DNA / RNA hybrids. The DNA / RNA hybrid pairing can additionally be weakened by modifying the DNA strand to form the phosphorothioate nucleic acid.
- the facilitated hybridization with a single strand in solution can also be achieved by a single strand end overhanging from the double strand probe.
- the hybridization then takes place with the single strand end and parts of the double strand structure. Is in the recognized double strand structure ⁇
- the newly formed hybrid can even detach completely from the probe and interrupt the flow of electrons within the probes.
- recombination events can also be detected and factors involved in the recombination, in particular enzymes, can be identified.
- factors involved in the recombination in particular enzymes, can be identified.
- the reaction solution is set recombination-promoting factors such. B. the recA protein from E. coli, then a faster decrease in electron flow or increased decrease in total electron flow can be measured.
- transposition events can also be determined. Since the strength of the electron flow in the double strand of the probe decreases with increasing distance, that is to say with increasing number of base pairs, between the electron donor unit or electron acceptor unit and the electrode, the electron flow also decreases when a transposon is integrated into the probe sequence , A corresponding increase in the electron flow can be demonstrated when the back reaction proceeds.
- the use of the double-stranded nucleic acid probes is also suitable for the detection of nucleic acid-damaging substances or for the detection of the nucleic acid-damaging effect of chemical substances.
- the damage to a double-stranded nucleic acid can be caused in different ways. Some substances, especially aromatic substances such as ethidium bromide or acridine, can intercalate into the nucleic acid dupiex structure.
- nucleic acids e.g. B. strong bases that hydrolyze the nucleic acids, benzopyrines that add to the nucleic acids or peroxides that easily form radicals and trigger radical chain reactions within the nucleic acid.
- B. strong bases that hydrolyze the nucleic acids benzopyrines that add to the nucleic acids or peroxides that easily form radicals and trigger radical chain reactions within the nucleic acid.
- benzopyrines that add to the nucleic acids or peroxides that easily form radicals and trigger radical chain reactions within the nucleic acid.
- the change in the nucleic acid structure these substances cause a change in the conductivity of the double-stranded nucleic acid probes.
- Such a test can be carried out in a compartmented reaction vessel in which the bottom surface is formed by the electrode in the form of an array.
- the probes are applied in a uniform density to the individual array positions.
- Each reaction compartment can be mixed with a reaction solution containing a different test substance.
- Reaction solutions can also be prepared which contain the same test substance in different concentrations. In this way, a simple test for identifying DNA-damaging and thus carcinogenic substances can be created.
- Double-stranded nucleic acids also interact with substances dissolved in the reaction medium, in particular with destabilizing ionic compounds. Interactions with the solvent itself can also affect the conductivity of the probes. For example, the dehydration of the DNA double helix of the B type changes to the A type. This transition can be measured using the novel probes.
- the reaction media or solutions can contain any solvents and additives.
- Aqueous, ionic buffer solutions which can contain chemical substances which interact with double-stranded nucleic acids are preferably used as reaction solutions.
- the direct use of raw extracts as a reaction medium is also possible.
- the detection of the interaction between the double-stranded nucleic acid probe sequences and the substances interacting therewith preferably takes place under physiological conditions in 10 to 200 mM aqueous, saline solutions at pH 7-9.
- a phosphate buffer is preferably used as the buffer.
- the measuring temperature is preferably between 4 and 40 ° C. A deviation from these measurement conditions can, however, be appropriate in individual cases. For example, an elevated measuring temperature can be used to find proteins with temperature-stable activity, such as the Taq polymerase used for the PCR. ⁇ & 0 this results in a variety of replaceability of the double-stranded nucleic acid
- Probes for the analysis of active factors interacting with nucleic acid or active double-stranded nucleic acid sequences are provided.
- the double-stranded nucleic acid probes according to the invention can be used in analytical devices with classic separation methods, such as. B. the chromatography can be combined. By separating cell extracts or substance libraries, active components that bind to a double-stranded nucleic acid can be quickly detected. The process can be operated continuously in an "online" measuring process.
- Suitable double-stranded nucleic acid probes can be produced using methods known to those skilled in the art. For this purpose, thiol groups are introduced into the nucleotide sequences that are to be incorporated into the probe for connection to a gold electrode and amino groups for connection to the electron donor units.
- oligonucleotides used if not commercially available, for. B. with a DNA synthesis method, the so-called phosphoramidite method (Beaucage, S. L .; Caruthers, M.H. Deoxynucleoside phosphoramidites.
- phosphoramidite method eaucage, S. L .; Caruthers, M.H. Deoxynucleoside phosphoramidites.
- the desired synthesis building blocks are made on a 1 ⁇ mol scale in a predetermined order on a solid CPG carrier material with the aid of a o2l Expedite Synthesizer of the type Expedite 8909 from PerSeptive Biosystems. To do this, the 0.1 M solutions of corresponding
- Phosphoramidite building blocks and 0.5 M tetrazole solution used Due to their sensitivity, the building blocks are dissolved in dry acetonitrile (water content ⁇ 30 ppm).
- the desired sequence is built up on the 3 'end of the oligonucleotide on thiol-CPG carrier material (Chemgenes) on a scale of 1 ⁇ mol.
- thiol-CPG carrier material Chevron Phillips Chemical Company
- a 0.02M iodine solution is used during the DNA synthesis (Kumar, A. et al., Nucleic Acids Research 1991, 19, 4561).
- the amino group can be removed using a 0.2 M solution AminoModifier II (Clontech) or 0.1 M solution Amino Modifier C6 dT (Glen Research) in dry acetonitrile (water ⁇ 30 ppm) at selected positions that are not on the electrode side of the double strand Structure, be introduced in a targeted manner.
- the modified oligonucleotides are worked up after completion of the syntheses.
- the oligomers are split off from the CPG support with aqueous ammonia solution (25-32%) and incubated at 55 ° C. for several hours.
- DTT is added up to a concentration of 50mM. The solution is then concentrated and the
- the sequence with phosphoamidite nucleotide building blocks is built up in the desired sequence on a 3 ' phosphate CPG, as described above.
- An AminoModifier II (Clontech) can be used as an amino-modified component.
- the oligonucleotide is esterified with (HO- (CH 2 ) 2 -S) 2 to give PO- (CH 2 ) 2 -SS- (CH 2 ) 2 -OH to introduce the required thiol function ,
- the nucleic acid in a concentration of 1-2X10 "4 M in application buffer (10 mM Tris, 1mM EDTA, pH 7.5 with the addition of 0.7 molar TEATFB) with 10 ⁇ -IO ' 1 molar Put 2-hydroxymercaptoethanol on the cleaned electrode gold surface and incubate for 2-24 hours.
- the metal surface is then cleaned with a 30% H 2 O 2 /70% H 2 SO solution and then immersed in ethanol for 20 minutes.
- the surface is covered with bidest. Water rinsed one last time.
- the preparation of commercially available precious metal electrodes can alternatively be carried out by polishing the electrode surface and subsequent rinsing.
- the subsequent electrochemical cleaning of the electrodes can, for. B. cyclic voltammetry in sodium hydroxide solution using a potentiostat, the electrodes several times in the potential range from -2.0 to +1, 2V against an Ag / Ag - Reference electrode (3M NaCI solution).
- As a counter electrode z. B. serve a platinum rod.
- connection of SH-modified oligonucleotides takes place e.g. B. by incubation of the cleaned Au electrodes with a solution of the corresponding oligonucleotide in phosphate buffer by dripping onto the gold disk and incubation for several hours in a water-saturated atmosphere.
- connection of an electron donor or acceptor unit such as. B. pyrroloquinolinequinone, methoxatin, PQQ or ferrocene can be carried out on the monolayer-bound or in solution oligonucleotides.
- the linkage of the redox units (PQQ, Sigma-Aldrich, Steinheim, D) to the primary amino group of the modified T-building block (aminomodifier dT) in the hairpin on monolayer-bound oligonucleotides is achieved by activating the PQQ carboxylate groups in buffer with a soluble carbodiimide and subsequent amide formation ,
- the second method of obtaining oligonucleotide monolayers on gold containing redox units is to modify the oligonucleotides with redox-active electron donor or acceptor units, such as. B. PQQ and ferrocene-acetic acid in solution and subsequent immobilization on the gold surface.
- a redox unit is linked by activating the carboxylate functions and then binding them to the primary amino group of the modified T building block (amino modifier dT) in the oligonucleotide.
- PQQ is dissolved in water and mixed with N-hydroxysuccinimide and water-soluble carbodiimide.
- the activation solution is mixed with water and triethylammonium hydrogen carbonate solution.
- the synthesis of the ferrocenacetic acid-modified oligonucleotides is carried out by activating the ferrocenacetic acid (e.g. with o- (benzotriazol-1-yl) -N, N, N ⁇ N > - tetramethyluronium tetrafluoroborate (TBTU)) and subsequent coupling with the free one Amino group of the oligonucleotide.
- the activated ferrocene acetic acid is added to a solution of the modifying oligonucleotide in the presence of a base. After a reaction time of several hours, the oligonucleotide is cleaned up.
- the covalent attachment of a Zn bacteriochlorophyll electron donor unit can take place after attachment of the nucleic acid to the electrode gold surface and a further washing step with water.
- the modified nucleic acid substrate with a solution of 3x10 "3 molar quinone 2- (CH 2 -CH 2 - CO 2 H-UQ-50), 10 " 2 molar EDC (3 ' -dimethylaminopropyl) -N-carbodiimide and 10 " 2 molar N-hydroxysulfsuccinimide in 0.1 M HEPES buffer (2- (4-2-hydroxyethyl) -1-piperazino) -ethanesulfonic acid, pH 7.5)
- the quinone used is obtained by cleaving a methoxy group by HBr (ether cleavage) as standard
- the resulting free hydroxyl group is reacted with an equimolar amount of CI-CH 2 -CH 2 -CO 2 H and then purified
- the modified substrate is washed with bidist.
- Water again with an aqueous solution of 3x 10 "3 molar Zn bacteriochlorophyll (as free acid), 1, 5x 10 " 1 molar (3-dimethylaminopropyl) carbodiimide, 2, 5x10 "3 molar hydrazine monohydrate and 1x10 " 1 molar imidazole incubated for 16 hours at 23 ° C.
- the Zn bacteriochlorophyll as free acid is produced by incubation with trifluoroacetic acid.
- the hybridization or refolding of the nucleic acids to the double-stranded probes can take place before or after application of the modified nucleic acid on the electrode gold surface.
- the hybridization can e.g. B. according to Methods known to those skilled in the art are carried out in a buffered solution.
- Hybridized nucleic acid duplexes are preferably used in the manufacture of the probes.
- the hybridization takes place under controlled conditions with slow cooling in order to avoid mismatches as far as possible. Short-term heating to 95 ° C and slow cooling down to room temperature in a water bath have proven to be effective.
- Applied single-stranded 5 * -phosphorylated (phosphate-on-phosphoramidite building blocks (Hörn, T. and Urdea, M., Tetrahedron Letter, 1986, 27, 4705)) and nucleic acids esterified to the thiol, which only have a short hairpin with free 3 ' OH end, can be built up enzymatically with the help of a DNA polymerase to a double strand.
- z. B. incubated a DNA structure with a mixture of the four nucleotide triphosphates with Klenow fragment of DNA I polymerase. The desired nucleic acid duplexes are obtained.
- the coating, preferably a monomolecular coating, of the free electrode surface has proven to be advantageous.
- the surface of a gold electrode can e.g. B. with alkyl disulfides, alkyl thiols or hydroxyalkyl thiols after application of the double-stranded nucleic acid probes.
- a double-stranded DNA structure (11) with a restriction site and a light-inducible electron donor unit (12) is covalently bound to a gold electrode (13) as described in the previous examples.
- the DNA double strand (11) of the probe is in a restriction enzyme z. B. Pst1 (14) containing reaction solution cut into two fragments (17, 18). The activity is measured over time under the influence of light (15) using an evaluation device (16).
- ligation of DNA-Zn bacteriochlorophyll degradation products e.g. B. from the reaction solution generated above, after the solution has been freed from the restriction enzyme by RP-HPLC, enzymatically linked again.
- the fragment can be ligated in excess of a ligase in a DNA ligase buffer, the efficiency is detected amperometrically by generating an electron flow through the double-stranded DNA.
- the addition of the transcription factor (21), e.g. B. Oct2A, TATA or Sp1 is carried out in a buffered solution on a template consisting of a gold electrode (22) which has double-stranded nucleic acid probes (23) with the respective binding site specific for the transcription factor.
- the double-stranded DNA probe sequences (23) are with a covalently bound light-inducible electron donor unit (24), for. B. Zn bacteriochlorophyll provided.
- the reading is carried out under light irradiation (25) with an evaluation unit (26).
- B. DNA fragments (27) not bound to the electrode surface of the respective transcription factor are carried in excess as a competitor.
- a self-complementary DNA (31) with a covalently bound light-inducible electron donor unit (34) is applied to the gold electrode (32) according to the examples listed above.
- a range of nucleotides is conceptually present at the 3 ' end as a single strand.
- a longer oligomer e.g. B. a 38 oligomer (33), which has a complementarity over a region of the other nucleic acid strand
- the single strand structure is specifically filled.
- z. B. an excess of buffered oligomer (33) is added to the bound probes and the mixture is then incubated. The excess of non-hybridized oligonucleotides is then washed out.
- a second buffered solution containing complementary oligomeric single-stranded nucleic acids this can be done in the present case e.g. B. a 38-oligomer (35) complementary to the oligomer (33), the re-hybridization under the influence of light (36) to form a hybrid (37) formed from the oligomers (33) and (35) with the aid of an evaluation unit ( 38) measured.
- Fig. 4 describes an assay to investigate the intercalation of chemical substances in double-stranded DNA.
- double-stranded nucleic acid probes (41) with a covalently bound light-inducible electron donor unit (46) are applied to a matrix-shaped gold electrode array surface (42) at the individual array positions (47).
- the bound DNA probes (41) are mixed with differently concentrated solutions of substances A, e.g. B. propidium iodide (43), B, e.g. B. ethidium bromide (44) and C, e.g. B. Syber ® green (45) incubated.
- substances A e.g. B. propidium iodide (43)
- B e.g. B. ethidium bromide
- C e.g. B. Syber ® green
- Evaluation unit (49) tracked.
- the separately readable array positions deliver substance and concentration-dependent signals (50).
- FIGS. 5 to 13 show the measurement curves determined by means of differential pulse voltammetry in accordance with the following exemplary embodiments.
- the Au electrodes are cleaned by polishing the electrode surface with an 3.3 ⁇ m alumina suspension (LECO, St. Joseph, USA) and subsequent rinsing with Millipore water (10 M ⁇ cm).
- the subsequent electrochemical cleaning of the electrodes is carried out in 0.2M NaOH using cyclic voltammetry (potentiostat: EG&G PAR 273A, GB), the electrodes first 5 times between potentials of -0.5 and -1.8V (against Ag / AgCI reference electrode ( 3M NaCI) and then 3 times between -0.8 and 1.0 V (feed rate 50 mV sec "1 ).
- a platinum rod serves as the counter electrode.
- Example 2 Methods for modifying Au electrodes with redox-labeled oligonucleotides
- Double-stranded nucleic acids were used for the modification.
- the hybridization takes place in the stock solution (1 mmol / l solution of the self-complementary single-stranded nucleic acids in water), which were heated to 95 ° C. in a water bath and slowly cooled to room temperature within 2 to 4 hours.
- Method A Modification of oligonucleotide monolayers with a redox label
- Steinheim, D supports the connection "* v9on ferrocene modified oligonucleotides) by spotting 5 ul of this solution onto the gold disc and 4-5 hours of incubation at 4 C C in a water-saturated atmosphere.
- the resulting oligonucleotide monolayers are characterized by blocking the diffusion-controlled Fe (II / III) redox reaction in aqueous K 3 / K 4 Fe (CN) 6 solution (salts from Merck, Darmstadt, D) (20 mM in 20 mM phosphate buffer pH 7) checked by means of cyclic voltammetry (CV).
- the linkage of the redox label (PQQ, Sigma-Aldrich, Steinheim, D) to the primary amino group of the modified T building block (aminomodifier dT) in the hairpin is activated by activating the PQQ carboxylate groups with a water-soluble
- the second method of obtaining redox-labeled oligonucleotide monolayers on gold is to modify the oligonucleotides with redox-active groups (PQQ and ferrocene-acetic acid) in solution and then immobilize them on the gold surface.
- redox-active groups PQQ and ferrocene-acetic acid
- the PQQ redox functions are linked by activation of the carboxylate functions and their subsequent binding to the primary amino group of the modified T building block (amino modifier dT) in the oligonucleotide.
- the precipitate was dissolved again by adding 50 ⁇ l of DMF. After a further 15 minutes, the solution is diluted with a further 145 ⁇ l of DMF.
- 120 ⁇ l of the activation solution are mixed with 3.7 ⁇ l of Millipore water and 3.2 ⁇ l of triethylammonium hydrogen carbonate solution (TEK buffer, 1 M, Fluka, Buchs, CH). After adding 10 OD of the amino-modified oligonucleotide, the solution is left to stand at room temperature for 24 hours. The reaction mixture is worked up by size exclusion chromatography on a Sephadex G25 M column (Amersham-Pharmacia Biotech AB, Uppsala, Sweden).
- the yields of oligonucleotide are usually between 70 and 90%.
- the oligonucleotides labeled with ferrocene acetic acid are synthesized by activating the ferrocene acetic acid with TBTU (Fluka) and subsequent coupling with the free amino group of the oligonucleotide.
- TBTU Frluka
- 4.9 ⁇ g of ferrocene acetic acid (Strem Chemicals, Kehl, D) are dissolved in 100 ⁇ l DMF in the first step.
- 75 ⁇ l of this solution are then added to a solution of 6 mg TBTU in 75 ⁇ l DMF and activated for 1 hour at room temperature.
- 10 ⁇ l of the oligonucleotide to be modified are mixed with 3.2 ⁇ l of TEK buffer. Then 25 ⁇ l of the activated are added
- the oligonucleotide is purified as described above.
- the electrodes are modified with the redox-labeled oligonucleotides in accordance with the instructions for the unmodified 5 ' thiol-amino-modified oligonucleotides.
- Example 3 Electrochemical experiments The electrochemical characterization of the redox-modified oligonucleotide monolayers takes place by means of cyclic voltammetry (CV) and differential pulse voltammetry (DPV) in 20 mM phosphate buffer pH 7.
- CV cyclic voltammetry
- DUV differential pulse voltammetry
- a signal of the reversible redox reaction occurs in one Potential of approx. -100 mV (against Ag / AgCI). This shows that the PQQ redox units are covalently bound via the nucleic acid oligomers on the modified electrode.
- the redox signals for ferrocenacetic acid-modified oligonucleotide monolayers occur at potentials of approx. +200 mV (against Ag / AgCI) and are generally broader and less intense than the corresponding PQQ signals.
- Curve (51) in FIG. 5 shows the DPV measurement result of a Zi6-PQQ electrode in 20 mM phosphate buffer at pH6.6, (reductive scan, 10 mV / s, step width 500 ms, pulse width 20 ms, pulse height 25 mV) the incubation with Hoechst 33258 curve (52) shows the DPV measurement result after incubation in 10 ⁇ M Hoechst 33258 in 1 M phosphate buffer for 20 min at RT.
- Examples 4 and 5 show sequence-unspecific interactions between proteins and DNA.
- sequence-specific interactions between redox-labeled DNA oligonucleotides and transcription factors are investigated.
- the oligonucleotide sequences used are listed in Table 1 together with their specific binding transcription factors (TKF).
- the SP1 transcription factor (as an extract from E-coli) was kindly provided by Prof. Suske (University of Marburg), the Oct2a-TKF was purchased from Röche as a kit with buffer solutions (DIG Gelshift Kit).
- HeLa-Scribe Nuclear Extract (Gel Shift Assay Grade, with SP1-TKF as a component), also as a kit (Gel Shift Assay Systems), and TATA binding protein were obtained from Promega.
- Incubation of a PQQ-Zi-3 oligonucleotide electrode containing an oligomer Seq. ID No. 1 in an Oct2a-TCF solution did not result in a change in the DPV redox signal after 60 minutes at room temperature (FIG. 7).
- curve (122) shows the redox signal after 30 minutes of incubation with a HeLa cell extract solution) and not to a reduction in the redox signal.
- TATA binding protein TATA binding protein
- a cleaned gold electrode was treated with 10O ⁇ M Zi-4-ferrocene acetic acid in 0.9M phosphate buffer (+ 1mM DTT), incubation time: 4 hours at 4 ° C.
- the monolayer gaps are passivated with mercaptohexanol (1 mM solution in H 2 O) for 1 hour at RT.
- the measurement is carried out in an electrolyte solution (20 mM potassium phosphate buffer pH 7.0) using the DPV (pulse height 25mV, feed rate 10mV / s, pulse duration 20ms, step size 500ms, potential against Ag / AgCI (3M NaCI)).
- curve (137) shows the effect of a 20 minute incubation of the electrode in 5 ⁇ l TFIID + 90 ⁇ l binding buffer on the reduction signal
- curve (138) shows the corresponding signal after 20 minutes incubation in 10 ⁇ l TFIID + 90 ⁇ l binding buffer)
- X represents a commercially available aminomodifier dT building block (formula I), the nucleotide building block located at the 5 ' end of the oligomer is modified on the C6 thiol (available from Interactiva).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
L'invention concerne des sondes pour acide nucléique à brin double pouvant être extraites par voie électronique et leur utilisation pour mettre en évidence de manière rapide et aisée les interactions entre des acides nucléiques à brin double et des facteurs qui entrent en interaction directement ou indirectement avec eux. L'invention concerne en outre des procédés permettant de produire des sondes pour acide nucléique à brin double.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19950969A DE19950969A1 (de) | 1999-10-22 | 1999-10-22 | Doppelstrang-Nukleinsäure-Sonden und deren Verwendung |
| DE19950969 | 1999-10-22 | ||
| PCT/EP2000/010209 WO2001031057A2 (fr) | 1999-10-22 | 2000-10-17 | Sondes pour acide nucleique a brin double et leur utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1226272A2 true EP1226272A2 (fr) | 2002-07-31 |
Family
ID=7926558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00969512A Withdrawn EP1226272A2 (fr) | 1999-10-22 | 2000-10-17 | Sondes pour acide nucleique a brin double et leur utilisation |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1226272A2 (fr) |
| JP (1) | JP2003512081A (fr) |
| KR (1) | KR20020065488A (fr) |
| AU (1) | AU7920100A (fr) |
| BR (1) | BR0015240A (fr) |
| CA (1) | CA2387567A1 (fr) |
| DE (1) | DE19950969A1 (fr) |
| WO (1) | WO2001031057A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004033476A1 (fr) * | 2002-10-11 | 2004-04-22 | Ahram Biosystems Inc. | Systeme de detection de cibles avec sonde sensible par sa conformation, comprenant un transducteur de signaux a base d'acides nucleiques |
| WO2004106545A1 (fr) * | 2003-05-28 | 2004-12-09 | Innogenetics N.V. | Procedes permettant une detection amelioree au moyen de techniques sensibles a la surface |
| EP2642291B1 (fr) * | 2009-08-07 | 2015-10-07 | Ohmx Corporation | Immuno-essai d'élimination chimique à modification redox déclenchée par une enzyme (E-trace) |
| US8877022B2 (en) * | 2011-06-21 | 2014-11-04 | National Taiwan University | Biosensor |
| JP6584986B2 (ja) * | 2016-03-18 | 2019-10-02 | 株式会社東芝 | 核酸検出方法 |
| US11840715B2 (en) * | 2020-06-30 | 2023-12-12 | Microsoft Technology Licensing, Llc | Microelectrode array with a switchable hydrophilic surface |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8919411D0 (en) * | 1989-08-25 | 1989-10-11 | Amersham Int Plc | Assay method |
| US5824473A (en) * | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| SE9502608D0 (sv) * | 1995-07-14 | 1995-07-14 | Pharmacia Biosensor Ab | Method for nucleic acid senquencing |
| AU739375B2 (en) * | 1996-11-05 | 2001-10-11 | Clinical Micro Sensors, Inc. | Electrodes linked via conductive oligomers to nucleic acids |
| US6306584B1 (en) * | 1997-01-21 | 2001-10-23 | President And Fellows Of Harvard College | Electronic-property probing of biological molecules at surfaces |
| AU7011898A (en) * | 1997-04-22 | 1998-11-13 | Thomas Schalkhammer | Reinforced cluster optical sensors |
| DE19741716A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Ag | Adressierbares modulares Erkennungssystem, seine Herstellung und Verwendung |
| US6242246B1 (en) * | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
| DE19901761A1 (de) * | 1999-01-18 | 1999-07-01 | Gerhard Dr Hartwich | Verfahren zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen |
| EP1210607A4 (fr) * | 1999-08-13 | 2004-12-22 | Nanogen Inc | Dispositifs a reseaux de descripteurs moleculaires microelectroniques, methodes, procedures et formats de selection combinatoire de structures de fixation de ligands intermoleculaires et de criblage de medicaments |
-
1999
- 1999-10-22 DE DE19950969A patent/DE19950969A1/de not_active Ceased
-
2000
- 2000-10-17 CA CA002387567A patent/CA2387567A1/fr not_active Abandoned
- 2000-10-17 WO PCT/EP2000/010209 patent/WO2001031057A2/fr not_active Ceased
- 2000-10-17 JP JP2001533192A patent/JP2003512081A/ja active Pending
- 2000-10-17 KR KR1020027005181A patent/KR20020065488A/ko not_active Withdrawn
- 2000-10-17 EP EP00969512A patent/EP1226272A2/fr not_active Withdrawn
- 2000-10-17 BR BR0015240-4A patent/BR0015240A/pt not_active Application Discontinuation
- 2000-10-17 AU AU79201/00A patent/AU7920100A/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0131057A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020065488A (ko) | 2002-08-13 |
| WO2001031057A2 (fr) | 2001-05-03 |
| BR0015240A (pt) | 2002-07-16 |
| AU7920100A (en) | 2001-05-08 |
| CA2387567A1 (fr) | 2001-05-03 |
| JP2003512081A (ja) | 2003-04-02 |
| WO2001031057A3 (fr) | 2001-12-27 |
| DE19950969A1 (de) | 2001-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69932236T2 (de) | Elektrochemischer sensor unter verwendung von interkalativen, redox-aktiven teilen | |
| DE60310532T2 (de) | Bestimmung von nukleinsäuren | |
| DE69430384T2 (de) | Nukleinsäurevermittelter elektronentransfer | |
| DE69433010T2 (de) | Verfahren zur darstellung von oligonukleotiden | |
| EP1133514A1 (fr) | Procede de detection electrochimique d'hybrides d'acides nucleiques-oligomeres | |
| EP1144685A2 (fr) | Procede de detection electrochimique d'hybridation d'acide nucleique-oligomere | |
| DE19926457A1 (de) | Verfahren zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen | |
| DE102011056606B3 (de) | Verfahren zur elektrochemischen Detektion von Nukleinsäureoligomer-Hybridisierungsereignissen | |
| EP1554396B1 (fr) | Essai de deplacement destine a la detection d'hybridations d'oligomeres d'acide nucleique | |
| EP1226272A2 (fr) | Sondes pour acide nucleique a brin double et leur utilisation | |
| EP1915464B1 (fr) | Procede de marquage et d'analyse d'acides nucleiques | |
| EP1307589A2 (fr) | Procede pour detecter des mutations dans des sequences nucleotidiques | |
| WO2000026402A1 (fr) | Procede et trousse de test pour analyser la reparation d'adn | |
| EP1831246B1 (fr) | Sonde pour detecter la presence d'acides nucleiques | |
| DE19921940C2 (de) | Verfahren zur elektrochemischen Detektion von Nukleinsäureoligomerhybriden | |
| WO2003018834A2 (fr) | Essai de deplacement destine a la detection d'hybridations d'oligomeres d'acide nucleique | |
| WO2002029092A2 (fr) | Unite active redox, photoinductible, thermostable destinee a la detection electrochimique de phenomenes d'hybridation d'un oligomere d'acides nucleiques | |
| WO2002064823A2 (fr) | Procédé pour détecter et/ou quantifier un analyte | |
| EP0996631A1 (fr) | Analogues d'acide nucleique modifies | |
| WO2026064468A1 (fr) | Procédés et compositions relatifs aux sondes fluorescentes à nanoclusters à base d'acides nucléiques | |
| WO2003040679A2 (fr) | Liaison reversible d'un fluorophore sur une surface pour detecter des phenomenes d'association ligat-ligand par extinction de fluorescence | |
| WO2003066890A2 (fr) | Procede permettant de determiner le modele de methylation d'adn | |
| DE10221091A1 (de) | SECM zur Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen | |
| WO2003040678A2 (fr) | Extinction de fluorescence pour detecter des phenomenes d'association ligat-ligand dans des champs electriques | |
| DE10221004A1 (de) | Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen unter Verwendung im wesentlichen ungeladener Ligat-Oligonukleotide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17P | Request for examination filed |
Effective date: 20020627 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MUTH, JOCHEN Inventor name: WINDHAB, NORBERT |
|
| 17Q | First examination report despatched |
Effective date: 20040316 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20040727 |